Advertisement

Pharmacy

The U.S. Health Resources & Services Administration launched a long-awaited website for safety-net providers participating in the 340B Drug Pricing Program April 1.

Novartis has agreed to acquire a subsidiary of IFM Therapeutics for a potential total of nearly $1.6 billion, including $310 million up front, and up to $1.27 billion in milestone payments, according to Reuters.

Advertisement

Court documents filed by Ohio Attorney General Dave Yost reveal that the state is planning more legal action against pharmacy benefit managers, according to The Columbus Dispatch.

Faced with rising drug costs and shrinking reimbursements, hospitals must look to optimize every area of their organization. Because medications impact virtually every service line of the hospital, the pharmacy is powerful – and often under-utilized – center of innovation.

Advertisement